BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 21991025)

  • 21. Reduction of catheter-related infections in neutropenic patients: a prospective controlled randomized trial using a chlorhexidine and silver sulfadiazine-impregnated central venous catheter.
    Jaeger K; Zenz S; Jüttner B; Ruschulte H; Kuse E; Heine J; Piepenbrock S; Ganser A; Karthaus M
    Ann Hematol; 2005 Apr; 84(4):258-62. PubMed ID: 15549302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative Efficacy of Antimicrobial Central Venous Catheters in Reducing Catheter-Related Bloodstream Infections in Adults: Abridged Cochrane Systematic Review and Network Meta-Analysis.
    Chong HY; Lai NM; Apisarnthanarak A; Chaiyakunapruk N
    Clin Infect Dis; 2017 May; 64(suppl_2):S131-S140. PubMed ID: 28475779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of chlorhexidine impregnated dressing and standard dressing for the prevention of central-line associated blood stream infection and colonization in critically ill pediatric patients: A randomized controlled trial.
    Duyu M; Karakaya Z; Yazici P; Yavuz S; Yersel NM; Tascilar MO; Firat N; Bozkurt O; Caglar Mocan Y
    Pediatr Int; 2022 Jan; 64(1):e15011. PubMed ID: 34610185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of chlorhexidine/silver sulfadiazine-impregnated central venous catheters in an intensive care unit with a low blood stream infection rate after implementation of an educational program: a before-after trial.
    Schuerer DJ; Zack JE; Thomas J; Borecki IB; Sona CS; Schallom ME; Venker M; Nemeth JL; Ward MR; Verjan L; Warren DK; Fraser VJ; Mazuski JE; Boyle WA; Buchman TG; Coopersmith CM
    Surg Infect (Larchmt); 2007 Aug; 8(4):445-54. PubMed ID: 17883361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short-term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial- and antiseptic-impregnated urethral catheters (the CATHETER trial).
    Pickard R; Lam T; Maclennan G; Starr K; Kilonzo M; McPherson G; Gillies K; McDonald A; Walton K; Buckley B; Glazener C; Boachie C; Burr J; Norrie J; Vale L; Grant A; N'dow J
    Health Technol Assess; 2012 Nov; 16(47):1-197. PubMed ID: 23199586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group.
    Darouiche RO; Raad II; Heard SO; Thornby JI; Wenker OC; Gabrielli A; Berg J; Khardori N; Hanna H; Hachem R; Harris RL; Mayhall G
    N Engl J Med; 1999 Jan; 340(1):1-8. PubMed ID: 9878638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiseptic-impregnated central venous catheters reduce the incidence of bacterial colonization and associated infection in immunocompromised transplant patients.
    George SJ; Vuddamalay P; Boscoe MJ
    Eur J Anaesthesiol; 1997 Jul; 14(4):428-31. PubMed ID: 9253572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults.
    Lai NM; Chaiyakunapruk N; Lai NA; O'Riordan E; Pau WS; Saint S
    Cochrane Database Syst Rev; 2013 Jun; (6):CD007878. PubMed ID: 23740696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impregnated central venous catheters for prevention of bloodstream infection in children (the CATCH trial): a randomised controlled trial.
    Gilbert RE; Mok Q; Dwan K; Harron K; Moitt T; Millar M; Ramnarayan P; Tibby SM; Hughes D; Gamble C;
    Lancet; 2016 Apr; 387(10029):1732-42. PubMed ID: 26946925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of silver-impregnated with standard multi-lumen central venous catheters in critically ill patients.
    Kalfon P; de Vaumas C; Samba D; Boulet E; Lefrant JY; Eyraud D; Lherm T; Santoli F; Naija W; Riou B
    Crit Care Med; 2007 Apr; 35(4):1032-9. PubMed ID: 17334256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are antiseptic-coated central venous catheters effective in a real-world setting?
    Borschel DM; Chenoweth CE; Kaufman SR; Hyde KV; VanDerElzen KA; Raghunathan TE; Collins CD; Saint S
    Am J Infect Control; 2006 Aug; 34(6):388-93. PubMed ID: 16877109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Double-lumen central venous catheters impregnated with chlorhexidine and silver sulfadiazine to prevent catheter colonisation in the intensive care unit setting: a prospective randomised study.
    Camargo LF; Marra AR; Büchele GL; Sogayar AM; Cal RG; de Sousa JM; Silva E; Knobel E; Edmond MB
    J Hosp Infect; 2009 Jul; 72(3):227-33. PubMed ID: 19443078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Types of urethral catheters for management of short-term voiding problems in hospitalized adults: a short version Cochrane review.
    Schumm K; Lam TB
    Neurourol Urodyn; 2008; 27(8):738-46. PubMed ID: 18951451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A prospective, randomized trial of rifampicin-minocycline-coated and silver-platinum-carbon-impregnated central venous catheters.
    Fraenkel D; Rickard C; Thomas P; Faoagali J; George N; Ware R
    Crit Care Med; 2006 Mar; 34(3):668-75. PubMed ID: 16505651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial impregnated catheters in the prevention of catheter-related bloodstream infection in hospitalized patients.
    Wassil SK; Crill CM; Phelps SJ
    J Pediatr Pharmacol Ther; 2007 Apr; 12(2):77-90. PubMed ID: 23055845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of central venous catheter type on infections: a prospective clinical trial.
    Richards B; Chaboyer W; Bladen T; Schluter PJ
    J Hosp Infect; 2003 May; 54(1):10-7. PubMed ID: 12767841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. No difference in catheter sepsis between standard and antiseptic central venous catheters. A prospective randomized trial.
    Pemberton LB; Ross V; Cuddy P; Kremer H; Fessler T; McGurk E
    Arch Surg; 1996 Sep; 131(9):986-9. PubMed ID: 8790170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retention of antibacterial activity and bacterial colonization of antiseptic-bonded central venous catheters.
    Bach A; Schmidt H; Böttiger B; Schreiber B; Böhrer H; Motsch J; Martin E; Sonntag HG
    J Antimicrob Chemother; 1996 Feb; 37(2):315-22. PubMed ID: 8707741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prevention of catheter-related infection: usefulness and cost-effectiveness of antiseptic catheters in children].
    Lenz AM; Vassallo JC; Moreno GE; Althabe M; Gómez S; Magliola R; Casimir L; Bologna R; Barretta J; Ruffa P
    Arch Argent Pediatr; 2010 Jun; 108(3):209-15. PubMed ID: 20544135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased bacterial adherence and biofilm formation on chlorhexidine and silver sulfadiazine-impregnated central venous catheters implanted in swine.
    Greenfeld JI; Sampath L; Popilskis SJ; Brunnert SR; Stylianos S; Modak S
    Crit Care Med; 1995 May; 23(5):894-900. PubMed ID: 7736748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.